Unveiling the vulnerability of C57BL/6J female mice to HFpEF and its related complications

Introduction: The impact of female biological sex on the development of heart failure with preserved ejection fraction (HFpEF) and its associated kidney disease and vascular endothelial dysfunction is still controversial. Whether females are protected from HFpEF and associated complications is not w...

Full description

Bibliographic Details
Main Authors: B. Srinivas, K. Alluri, H. Peng, P.A. Ortiz, J. Xu, H.N. Sabbah, N.E. Rhaleb, K. Matrougui
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Journal of Molecular and Cellular Cardiology Plus
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772976124000023
_version_ 1797258665701408768
author B. Srinivas
K. Alluri
H. Peng
P.A. Ortiz
J. Xu
H.N. Sabbah
N.E. Rhaleb
K. Matrougui
author_facet B. Srinivas
K. Alluri
H. Peng
P.A. Ortiz
J. Xu
H.N. Sabbah
N.E. Rhaleb
K. Matrougui
author_sort B. Srinivas
collection DOAJ
description Introduction: The impact of female biological sex on the development of heart failure with preserved ejection fraction (HFpEF) and its associated kidney disease and vascular endothelial dysfunction is still controversial. Whether females are protected from HFpEF and associated complications is not well established. Previous studies report conflicting prevalence between genders. We hypothesize that female mice are unprotected from HFpEF and its associated kidney disease and vascular endothelial dysfunction. Methods: Eight-week-old female mice were divided into four groups: control groups receiving a standard diet and water for either 5 or 16 weeks, and HFpEF groups fed a high-fat diet (HFD, Rodent Diet With 60 kcal% Fat) and N[w]-nitro-l-arginine methyl ester (L-NAME - 0.5 g/L) in the drinking water for 5 or 16 weeks. Various measurements and assessments were performed, including echocardiography, metabolic and hypertensive evaluations, markers of heart and kidney injury, and assessment of vascular endothelial function. Results: Female mice with HFD and L-NAME developed HFpEF at 5 weeks, evidenced by increased E/E' ratio, reduced cardiac index, left ventricular mass, and unchanged ejection fraction. After 16 weeks, HFpEF worsened. Metabolic disorders, hypertension, lung wet/kidney weight increase, exercise intolerance, and cardiac/renal injury markers were observed. Vascular endothelial dysfunction was associated with ER stress and fibrosis induction. Conclusions: We found that female mice are susceptible to the development of HFpEF and its associated kidney disease and vascular endothelial dysfunction. Our data support the concept that the female sex does not protect from HFpEF and its associated kidney disease and vascular endothelial dysfunction when disease risk factors are present.
first_indexed 2024-03-08T14:20:14Z
format Article
id doaj.art-7d073575785d4baabda9c14e41ba9a31
institution Directory Open Access Journal
issn 2772-9761
language English
last_indexed 2024-04-24T22:57:09Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Journal of Molecular and Cellular Cardiology Plus
spelling doaj.art-7d073575785d4baabda9c14e41ba9a312024-03-18T04:34:56ZengElsevierJournal of Molecular and Cellular Cardiology Plus2772-97612024-03-017100062Unveiling the vulnerability of C57BL/6J female mice to HFpEF and its related complicationsB. Srinivas0K. Alluri1H. Peng2P.A. Ortiz3J. Xu4H.N. Sabbah5N.E. Rhaleb6K. Matrougui7Department of Physiological Sciences, EVMS, Norfolk, VA 23501, USADepartment of Physiological Sciences, EVMS, Norfolk, VA 23501, USADepartment of Physiology, Wayne State University, Detroit, MI 48202, USA; Internal Medicine Department, Hypertension and Vascular Research, Detroit, MI 48202, USADepartment of Physiology, Wayne State University, Detroit, MI 48202, USA; Internal Medicine Department, Hypertension and Vascular Research, Detroit, MI 48202, USAInternal Medicine Department, Cardiovascular Medicine, Detroit, MI 48202, USAInternal Medicine Department, Cardiovascular Medicine, Detroit, MI 48202, USADepartment of Physiology, Wayne State University, Detroit, MI 48202, USA; Internal Medicine Department, Cardiovascular Medicine, Detroit, MI 48202, USADepartment of Physiological Sciences, EVMS, Norfolk, VA 23501, USA; Corresponding author.Introduction: The impact of female biological sex on the development of heart failure with preserved ejection fraction (HFpEF) and its associated kidney disease and vascular endothelial dysfunction is still controversial. Whether females are protected from HFpEF and associated complications is not well established. Previous studies report conflicting prevalence between genders. We hypothesize that female mice are unprotected from HFpEF and its associated kidney disease and vascular endothelial dysfunction. Methods: Eight-week-old female mice were divided into four groups: control groups receiving a standard diet and water for either 5 or 16 weeks, and HFpEF groups fed a high-fat diet (HFD, Rodent Diet With 60 kcal% Fat) and N[w]-nitro-l-arginine methyl ester (L-NAME - 0.5 g/L) in the drinking water for 5 or 16 weeks. Various measurements and assessments were performed, including echocardiography, metabolic and hypertensive evaluations, markers of heart and kidney injury, and assessment of vascular endothelial function. Results: Female mice with HFD and L-NAME developed HFpEF at 5 weeks, evidenced by increased E/E' ratio, reduced cardiac index, left ventricular mass, and unchanged ejection fraction. After 16 weeks, HFpEF worsened. Metabolic disorders, hypertension, lung wet/kidney weight increase, exercise intolerance, and cardiac/renal injury markers were observed. Vascular endothelial dysfunction was associated with ER stress and fibrosis induction. Conclusions: We found that female mice are susceptible to the development of HFpEF and its associated kidney disease and vascular endothelial dysfunction. Our data support the concept that the female sex does not protect from HFpEF and its associated kidney disease and vascular endothelial dysfunction when disease risk factors are present.http://www.sciencedirect.com/science/article/pii/S2772976124000023HFpEFFemale miceVascular endothelia dysfunctionKidney failureInflammationER stress
spellingShingle B. Srinivas
K. Alluri
H. Peng
P.A. Ortiz
J. Xu
H.N. Sabbah
N.E. Rhaleb
K. Matrougui
Unveiling the vulnerability of C57BL/6J female mice to HFpEF and its related complications
Journal of Molecular and Cellular Cardiology Plus
HFpEF
Female mice
Vascular endothelia dysfunction
Kidney failure
Inflammation
ER stress
title Unveiling the vulnerability of C57BL/6J female mice to HFpEF and its related complications
title_full Unveiling the vulnerability of C57BL/6J female mice to HFpEF and its related complications
title_fullStr Unveiling the vulnerability of C57BL/6J female mice to HFpEF and its related complications
title_full_unstemmed Unveiling the vulnerability of C57BL/6J female mice to HFpEF and its related complications
title_short Unveiling the vulnerability of C57BL/6J female mice to HFpEF and its related complications
title_sort unveiling the vulnerability of c57bl 6j female mice to hfpef and its related complications
topic HFpEF
Female mice
Vascular endothelia dysfunction
Kidney failure
Inflammation
ER stress
url http://www.sciencedirect.com/science/article/pii/S2772976124000023
work_keys_str_mv AT bsrinivas unveilingthevulnerabilityofc57bl6jfemalemicetohfpefanditsrelatedcomplications
AT kalluri unveilingthevulnerabilityofc57bl6jfemalemicetohfpefanditsrelatedcomplications
AT hpeng unveilingthevulnerabilityofc57bl6jfemalemicetohfpefanditsrelatedcomplications
AT paortiz unveilingthevulnerabilityofc57bl6jfemalemicetohfpefanditsrelatedcomplications
AT jxu unveilingthevulnerabilityofc57bl6jfemalemicetohfpefanditsrelatedcomplications
AT hnsabbah unveilingthevulnerabilityofc57bl6jfemalemicetohfpefanditsrelatedcomplications
AT nerhaleb unveilingthevulnerabilityofc57bl6jfemalemicetohfpefanditsrelatedcomplications
AT kmatrougui unveilingthevulnerabilityofc57bl6jfemalemicetohfpefanditsrelatedcomplications